Complex cytokine profiles induced by BCG vaccination in UK infants

[1]  M. Newport,et al.  Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. , 2009, The Journal of infectious diseases.

[2]  B. Samten,et al.  IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB. , 2009, The Journal of infectious diseases.

[3]  R. Adegbola,et al.  Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease , 2009, European journal of immunology.

[4]  P. V. van Helden,et al.  Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis , 2008, Clinical and experimental immunology.

[5]  S. Kaufmann,et al.  Tuberculosis in Africa: learning from pathogenesis for biomarker identification. , 2008, Cell host & microbe.

[6]  M. O'Donnell,et al.  Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guérin secreting murine GM-CSF is associated with expansion and activation of APCs , 2008, The Journal of Immunology.

[7]  S. Khader,et al.  IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.

[8]  R. Wilkinson,et al.  Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response1 , 2008, The Journal of Immunology.

[9]  H. Dockrell,et al.  Persistence of the immune response induced by BCG vaccination , 2008, BMC infectious diseases.

[10]  B. Thiers,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2008 .

[11]  C. Jagannath,et al.  Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. , 2008, Tuberculosis.

[12]  P. Méndez-Samperio,et al.  Mycobacterium bovis Bacillus Calmette-Guérin Induces CCL5 Secretion via the Toll-Like Receptor 2-NF-κB and -Jun N-Terminal Kinase Signaling Pathways , 2007, Clinical and Vaccine Immunology.

[13]  R. Koup,et al.  Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations , 2007, European journal of immunology.

[14]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[15]  A. O’Garra,et al.  TH1 cells control themselves by producing interleukin-10 , 2007, Nature Reviews Immunology.

[16]  D. McMurray,et al.  Current status of TB vaccines. , 2007, Vaccine.

[17]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[18]  S. Nakae,et al.  IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guérin Infection1 , 2007, The Journal of Immunology.

[19]  L. Harrington,et al.  Expanding the effector CD4 T-cell repertoire: the Th17 lineage. , 2006, Current opinion in immunology.

[20]  Alimuddin Zumla,et al.  Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. , 2006, Tuberculosis.

[21]  S. Nakae,et al.  The role of TNFalpha and IL-17 in the development of excess IL-1 signaling-induced inflammatory diseases in IL-1 receptor antagonist-deficient mice. , 2006, Ernst Schering Research Foundation workshop.

[22]  J. Flynn,et al.  Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  K. Dheda,et al.  IL-4 in tuberculosis: implications for vaccine design. , 2004, Trends in immunology.

[24]  H. Dockrell,et al.  Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. , 2004, The Journal of infectious diseases.

[25]  S. Nakae,et al.  IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  I. Homma,et al.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. , 2002, Immunity.

[27]  H. Dockrell,et al.  Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. , 2002, Journal of immunological methods.

[28]  J. Blackwell,et al.  BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies , 2002, The Lancet.

[29]  H. Dockrell,et al.  Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients. , 2002, Tuberculosis.

[30]  G. Rook,et al.  Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. , 2000, The Journal of infectious diseases.

[31]  R. North.  Mice incapable of making IL‐4 or IL‐10 display normal resistance to infection with Mycobacterium tuberculosis , 1998, Clinical and experimental immunology.

[32]  H. Whittle,et al.  Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[33]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[34]  P. E. M. Fine,et al.  Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.

[35]  M. Troye-Blomberg,et al.  Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. , 1994, Immunology.

[36]  V. Diwan,et al.  Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. , 1993, International journal of epidemiology.

[37]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[38]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[39]  M. de Carli,et al.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. , 1993, Journal of immunology.

[40]  A. Wadee,et al.  Supernatants derived from CD8+ lymphocytes activated by mycobacterial fractions inhibit cytokine production. The role of interleukin-6 , 1992, Biotherapy.